You just read:

New study results show Tradjenta® (linagliptin) reduces blood sugar in adults with type 2 diabetes at risk for kidney impairment

News provided by

Eli Lilly and Company; Boehringer Ingelheim

Jun 11, 2016, 11:00 ET